Eisai
4523.T
$25.34
Share price
1.74%
Change (1 day)
-37.18%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Earnings for Eisai (4523.T)
Earnings in 2024 (TTM): $0.43 Billion USD
According to Eisai's latest financial reports the company's current earnings are $5.06 Billion USD. In 2023 the company made an earning of $0.52 Billion USD, an increase over its 2022 earnings that were of -$22.86 Million USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eisai from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | $0.43 B | -16.5% |
| 2023 | $0.52 B | -2392.87% |
| 2022 | -$22.86 Million | -103.6% |
| 2021 | $0.63 B | -39.52% |
| 2020 | $1.04 B | 7.3% |
| 2019 | $0.97 B | 17.23% |
| 2018 | $0.83 B | 86.06% |
| 2017 | $0.44 B | -23.64% |
| 2016 | $0.58 B | 27.28% |
| 2015 | $0.46 B | 22.08% |
| 2014 | $0.37 B | -46.11% |
| 2013 | $0.70 B | -21.67% |
| 2012 | $0.89 B | -20.72% |
| 2011 | $1.13 B | -8.44% |
| 2010 | $1.23 B | 18.85% |
| 2009 | $1.03 B |